$76 Million Acquisition of Pharmaceutical Company

We represented Footstar, Inc. in connection with the formation of a joint venture to facilitate the acquisition of CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX), a specialty pharmaceutical company, in a transaction valued at approximately $76 million.  The transaction was financed through a combination of equity and debt.

• Joint Ventures & Strategic Alliances